Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients

Pierre-Étienne Heudel; Bertrand Favier; Marie-Laure Solodky; Souad Assaad; Natacha Chaumard; Olivier Trédan; Thomas Bachelot; I. L. Ray-Coquard; Bruno Russias; Marie‐Line Fournier; Bénédicte Mastroïanni; Virginie Avrillon; Anne‐Sophie Michallet; Philippe Zrounba; Sylvie Chabaud; David Pérol; Jean Yves Blay

doi:10.1016/j.ejca.2022.01.035

Related publications

Article2021

Survival and Incidence of COVID-19 After SARS-CoV-2 Vaccination in a Series of 2391 Cancer Patients

Pierre-Étienne Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Trédan, Thomas Bachelot, I. Ray-Coquard, Bruno Russias, Marie‐Line Fournier, Bénédicte Mastroïanni, Virginie Avrillon, Anne‐Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol, Jean Yves Blay

Letter2021

Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

Pierre-Étienne Heudel, Bertrand Favier, Souad Assaad, Philippe Zrounba, Jean Yves Blay

Letter2021

Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19

Laurens J. Ceulemans, Mona Khan, Seung‐Jun Yoo, Bolek Zapiec, Laura Van Gerven, Jan Van Slambrouck, Arno Vanstapel, Dirk Van Raemdonck, Robin Vos, Els Wauters, Joost Wauters, Peter Carmeliet, Peter Mombaerts

Article2021

Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis

Efstathios Kastritis, Evangelos Terpos, Aimilia D. Sklirou, Foteini Theodorakakou, Despina Fotiou, Eleni‐Dimitra Papanagnou, Tina Bagratuni, Nikolaos Kanellias, Maria Gavriatopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos

Article2021

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors

Flora Zagouri, Evangelos Terpos, Oraianthi Fiste, Michalis Liontos, Αlexandros Briasoulis, Ioanna Katsiana, Efi Skafida, Christos Markellos, Elena Kunadis, Αngeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Maria Gavriatopoulou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos

Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients

Discussion(0)

Related publications

Survival and Incidence of COVID-19 After SARS-CoV-2 Vaccination in a Series of 2391 Cancer Patients

Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients

Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19

Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors